MWNA
PAVM icon

Marshall Wace North America’s PAVmed PAVM Stock Holding History

Marshall Wace North America’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-403
Closed -$1.16M – 1638
2021
Q2 		$1.16M Sell
403
-986
-71% -$2.33M ﹤0.01% 969
2021
Q1 		$2.78M Buy
+1,389
New +$2.09M 0.01% 723

Other funds holding PAVM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Marshall Wace North America's PAVM Position: Q3 2021 in Review

Marshall Wace North America sold out of PAVmed (PAVM) in Q3 2021, closing a stake of 403 shares — an estimated $1.16M sold.

Marshall Wace North America first reported a position in PAVM in Q1 2021 and held it in 2 quarters. The position peaked at $2.78M in Q1 2021. 107 funds tracked by Wall St. Rank hold PAVM as of Q3 2021.

  • Marshall Wace North America reported no remaining PAVmed position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 403 PAVmed shares in Q3 2021, an estimated $1.16M.
  • Marshall Wace North America first reported a position in PAVmed in Q1 2021 and held it in 2 quarters.
  • Marshall Wace North America's PAVmed position peaked at $2.78M in Q1 2021.
  • 107 funds tracked by Wall St. Rank held PAVmed as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.